You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
Combining questionnaire-derived phenotyping with hospital diagnoses increases the power to tease out genetic associations within biobank data.
The plaintiffs allege that TAI's heart transplant rejection test MyTAIHeart infringes on their patent for the non-invasive diagnosis of graft rejection.
The molecular laboratory-developed test was authorized for use only in the Stanford Health Care Clinical Virology Laboratory.
The approach, called Lung-CLiP, couples machine learning trained on epigenetic and clonal frequency data with the detection of alterations in blood-borne DNA.
Investigators worldwide are sharing data to search for features in the human genome that might contribute to COVID-19 susceptibility or progression.
In Nature this week: single-cell transcriptomic data to map human tissue, combined genomic and machine learning approach for non-invasive early lung cancer screening, and more.
New Scientist writes that researchers have genetically modified nerve cells to produce electrically functional polymers.
A proof-of-concept study shows the possibility of using CRISPR-based tools to combat pandemics, Wired reports, noting that much more work is needed.
Researchers found that more than 3 percent of postmenopausal women with breast cancer but no other disease risk factors carried pathogenic variants.
Multi-omics approaches can give insight into the gut microbiome and more, but there are still challenges to address, speakers at the ABRF meeting said.
Following discrimination allegations, NICHD's Constantine Stratakis withdraws from a new position at the Research Institute of the McGill University Health Center, Science reports.
US President Donald Trump has threatened to cut World Health Organization funding over its pandemic response, which would affect its ability to do its work and which he might not be able to do.
The US Securities and Exchange Commission has halted the sales of a handful of stocks over claims made about the coronavirus.
In Nature this week: comparative analyses of single-cell RNA sequencing protocols uncover differences between approaches, and more.